month-old Japanese girl with hereditary orotic aciduria type I was treated with oral Uridine supplement. The activities of orotate phosphoribosyltransferase (OPRT) and orotidine-5'-phosphate decarboxylase (ODC) in erythrocytes were 2.7 and 0.4%, respectively, of those in the controls. Megaloblastic anemia, excessive urinary excretion of orotic acid, lymphopenia and decreased number of OKT3 positive lymphocytes on admission were corrected after the uridine supplement. Peripheral blood lymphocytes (PBL) were cultured for 24 hr in RPMI 1640 medium with 10% heat-inactivated fetal calf serum and further stimulated with PHA-P, ConA or PWM in the presence of 10 to 1000 jiM uridine. EB virus-transformed B cell line (LCL) maintained with an optimal concentration of uridine was cultured for 48 hr in uridine free medium and cultured for an additional 48 hr with 1 to 1000 ,uM uridine. The incorporations of leucine in to PHA-, ConA-and PWMstimulated PBL and into LCL of the patient increased in the presence of uridine over 10 ,a M, although they did not increase in controls. These data suggest that low protein synthesis might correlate with an immune deficiency in hereditary orotic aciduria type I. uridine supplement ; hereditary orotic aciduria type I ; immune deficiency Hereditary orotic aciduria is a rare inborn error of pyrimidine metabolism associated with megaloblastic anemia, retarded growth and excessive urinary excretion of orotic acid. The enzyme defect involves either two sequential enzymes of de novo pyrimidine biosynthesis, orotate phosphoribosyltransferase Morishita et al. 1986 ), or only ODC in type II form (Fox et al. 1969 (Fox et al. , 1973 .
Oral uridine supplement usually improves clinical and hematological abnormalities. Correction of abnormal RNA and DNA synthesis by uridine supplement has been postulated, though not demonstrated.
Three of twelve patients with this disease died from varicella or meningitis (Huguley et al. 1959; Fox et al. 1969; Girot et al. 1983 ). An immune deficiency has been suspected, although there are conflicting reports (Girot et al. 1983 (Girot et al. , 1984 Becroft et al. 1984) .
In this report, we describe uridine supplement has normalized the number of OKT3 positive lymphocytes and has increased protein synthesis in lectinstimulated peripheral blood lymphocytes (PBL) and EB virus-transformed B cell line (LCL) in vivo.
CASE REPORT A 2 month-old Japanese girl with severe anemia and ventricular septal defect was admitted to the Nagoya City University Hospital. Her parents were not related. Blood examination revealed erythrocytes of 1,910,000/mm3, hemoglobin 5.2 g/100 ml, and hematocrit 15.7%. Bone marrow examination revealed megaloblastic change with normal serum vitamin B12 and folic acid. Urinary excretion of orotic acid was 357 mg per day. The activities of OPRT and ODC in erythrocytes were 2.7 and 0.4%, respectively, of those in the controls. The activities of OPRT and ODC in LCL were 7.5 and 0.01%, respectively, of those in the controls. Family study revealed parents were heterozygotes.
METHODS
PBL were isolated by Ficoll-Isopaque gradient centrifugation. LCL was established using B95-8 derived EB virus. PBL were cultured for 24 hr in RPMI 1640 medium (GIBCO, Grand Island, NY, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS) before the assay. 1.25 x 105 PBL were further stimulated with phytohemagglutin-P (PHA-P) (Difco Laboratories, Detroit, MI, USA; 15pg/ml) for 4 days, concanavalin A (ConA) (Miles Laboratories, Inc., Elkhart, IN, USA; 12.5pg/ml) for 5 days or pokeweed mitogen (PWM) (GIBCO ; diluted 1 to 2400) for 5 days in the presence of 101uM to 100,aM uridine in flat-bottomed microtiter well containing 2001u1 RPMI 1640 with 10% heatinactivated FCS. LCL maintained with an optimal concentration of uridine was cultured for 48 hr with uridine free medium, and 1>< 105 LCL were cultured for an additional 48 hr with 1 to 1000,uM uridine in flat-bottomed microtiter well containing 200 p1 RPMI 1640 with 10% heat-inactivated FCS. 0.5pCi of [methyl-3H] thymidine (5 Ci/mmole, Amersham Japan, Tokyo) or 0.5pCi of L-[4, 5-3H] leucine (1 Ci/mmole, Amersham Japan) was added to each well 18 hr before the end of the culture. The cultured cells were harvasted onto glass fiber filters with a multiple sample havester. The radioactivity in the cells was counted by a liquid scintillation counter. The concentration of uridine in plasma was determined by high-performance liquid chromatography (Mizuguchi 1983 ).
RESULTS
Immunological investigations were performed at 3 month-old before oral uridine supplement (Table 1) . Levels of serum immunoglobulin were normal for her age. Total lymphocytes were 1,760/mm3 with low number of OKT3 positive lymphocytes and high number of OKIal positive lymphocytes as in the patients reported by Girot et al. (1983) . Although megaloblastic anemia, excessive excretion of orotic acid, lymphopenia and decreased number of OKT3 positive lymphocytes were corrected at 8 month-old after 5 months uridine therapy (Fig.  1, Table 1 ), a skin test for PHA (10 1u g) was weak positive and challenge with dinitrochlorobenzene was negative. To study the effect of uridine on lymphocytes in vitro, we cultured lectin-stimulated PBL and LCL in the presence of 10 to 1000 p M uridine at 1 year and 2 month-old after 11 months of uridine therapy. As shown in Tables 2 and 3 , the incorporation of leucine into PHA-, ConA-and PWM-stimulated PBL and into LCL were increased in the patient by the addition of uridine, although that in control remained unchanged. The incorporation of thymidine in patient's LCL increased in the presence of 10 pM uridine, although that in control's LCL did not (Table 3 ). 
DISCUSSION
Threre are conflicting reports whether or not hereditary orotic aciduria involves an immune deficiency. The cases whom Girot et al. (1983) reported had lymphopenia, low number of OKT3 positive lymphocytes, a decrease in T-cellmediated lymphocytolysis and an absence of PWM-induced plasma cell generation, although the case reported whom by Becroft et al. (1984) had no immunological abnormalities.
Our case had lymphopenia and low number of OKT3 positive lymphocyte before the uridine therapy. We found uridine supplement increased the incorporation of leucine in lectin-stimulated PBL and LCL in vitro. These results suggest that uridine supplement might increase the important factors in immune response, then protect patients with this disease from severe infection. Since both the case of Huguley et al. (1959) and the case of Fox et al. (1969) had severe infection when they stopped nucleotide intake, continuous uridine supplement should be needed in order to maintain normal immune response. Uridine supplement increased the incorporation of thymidine in patient's LCL. This result might be correlated with the megaloblastic change in erythroblasts. 
